HK1119956A1 - Carrier composition for nucleic acid transport - Google Patents

Carrier composition for nucleic acid transport

Info

Publication number
HK1119956A1
HK1119956A1 HK08114132.2A HK08114132A HK1119956A1 HK 1119956 A1 HK1119956 A1 HK 1119956A1 HK 08114132 A HK08114132 A HK 08114132A HK 1119956 A1 HK1119956 A1 HK 1119956A1
Authority
HK
Hong Kong
Prior art keywords
nucleic acid
carrier composition
acid transport
transport
carrier
Prior art date
Application number
HK08114132.2A
Other languages
English (en)
Inventor
Hidekazu Toyobuku
Hideo Miyao
Masako Sato
Kazuo Sekiguchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1119956A1 publication Critical patent/HK1119956A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK08114132.2A 2005-10-18 2008-12-31 Carrier composition for nucleic acid transport HK1119956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005303497 2005-10-18
PCT/JP2006/320617 WO2007046356A1 (ja) 2005-10-18 2006-10-17 核酸送達用キャリアー組成物

Publications (1)

Publication Number Publication Date
HK1119956A1 true HK1119956A1 (en) 2009-03-20

Family

ID=37962449

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08114132.2A HK1119956A1 (en) 2005-10-18 2008-12-31 Carrier composition for nucleic acid transport
HK12112608.5A HK1171689A1 (en) 2005-10-18 2012-12-06 Carrier composition for nucleic acid transport

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12112608.5A HK1171689A1 (en) 2005-10-18 2012-12-06 Carrier composition for nucleic acid transport

Country Status (20)

Country Link
US (1) US8030075B2 (xx)
EP (1) EP1946761B8 (xx)
JP (1) JP5046952B2 (xx)
KR (1) KR101324065B1 (xx)
CN (2) CN102512689B (xx)
AR (1) AR057553A1 (xx)
AU (1) AU2006305318B2 (xx)
BR (1) BRPI0617449A2 (xx)
CA (1) CA2624840A1 (xx)
CY (1) CY1114586T1 (xx)
DK (1) DK1946761T3 (xx)
ES (1) ES2412029T3 (xx)
HK (2) HK1119956A1 (xx)
MY (1) MY149502A (xx)
PL (1) PL1946761T3 (xx)
PT (1) PT1946761E (xx)
RU (1) RU2421227C2 (xx)
SI (1) SI1946761T1 (xx)
TW (1) TW200800235A (xx)
WO (1) WO2007046356A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800235A (en) * 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
EP3721943A1 (en) 2009-12-23 2020-10-14 Novartis AG Lipids, lipid compositions and methods of using them
EP2548958B1 (en) 2010-03-15 2017-11-22 Yamaguchi University Agent for improving gene transfer efficiency to mammalian cells
AU2013266238B2 (en) * 2012-05-23 2017-07-27 The Ohio State University Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same
US9833416B2 (en) * 2014-04-04 2017-12-05 Ohio State Innovation Foundation Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
US20180355345A1 (en) * 2015-07-30 2018-12-13 Arcis Biotechnology Holdings Limited Method and composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092180A1 (en) 2001-08-27 2003-05-15 David Lewis Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
US5965542A (en) * 1997-03-18 1999-10-12 Inex Pharmaceuticals Corp. Use of temperature to control the size of cationic liposome/plasmid DNA complexes
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
JP4854853B2 (ja) * 1998-11-12 2012-01-18 ライフ テクノロジーズ コーポレーション トランスフェクション薬剤
AU2002214854A1 (en) * 2000-10-25 2002-05-06 Inex Pharmaceuticals Corporation Lipid formulations for target delivery
US20020187105A1 (en) * 2001-02-01 2002-12-12 Yiyu Zou Polymer combinations that result in stabilized aerosols for gene delivery to the lungs
US20030096414A1 (en) * 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
US7713942B2 (en) * 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
CA2465860A1 (en) * 2001-11-02 2004-04-22 Insert Therapeutics, Inc. Methods and compositions for therapeutic use of rna interference
RU2311911C2 (ru) * 2002-07-05 2007-12-10 Липоксен Текнолоджиз Лимитед Способ усиления иммунного ответа при вакцинации нуклеиновой кислотой
AU2004257373B2 (en) * 2003-07-16 2011-03-24 Arbutus Biopharma Corporation Lipid encapsulated interfering RNA
JP2008520209A (ja) 2004-11-17 2008-06-19 ユニヴァーシティ・オブ・メリーランド，バルチモア ｓｉＲＮＡの有効なキャリアとしての高度に枝分かれしたＨＫペプチド
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
TW200800235A (en) * 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport

Also Published As

Publication number Publication date
KR101324065B1 (ko) 2013-10-31
WO2007046356A1 (ja) 2007-04-26
CN102512689B (zh) 2014-08-20
CY1114586T1 (el) 2016-10-05
PT1946761E (pt) 2013-05-27
KR20080059648A (ko) 2008-06-30
RU2421227C2 (ru) 2011-06-20
JPWO2007046356A1 (ja) 2009-04-23
EP1946761A4 (en) 2012-01-25
TWI376225B (xx) 2012-11-11
TW200800235A (en) 2008-01-01
CN101291678B (zh) 2012-03-28
DK1946761T3 (da) 2013-04-15
MY149502A (en) 2013-09-13
AU2006305318A1 (en) 2007-04-26
ES2412029T3 (es) 2013-07-09
CA2624840A1 (en) 2007-04-26
HK1171689A1 (en) 2013-04-05
CN102512689A (zh) 2012-06-27
JP5046952B2 (ja) 2012-10-10
EP1946761B1 (en) 2013-04-03
EP1946761B8 (en) 2013-05-22
US20090258923A1 (en) 2009-10-15
SI1946761T1 (sl) 2013-06-28
AR057553A1 (es) 2007-12-05
RU2008119498A (ru) 2009-11-27
AU2006305318B2 (en) 2011-08-25
CN101291678A (zh) 2008-10-22
US8030075B2 (en) 2011-10-04
PL1946761T3 (pl) 2013-08-30
BRPI0617449A2 (pt) 2011-07-26
EP1946761A1 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
EP1850870A4 (en) COMPOSITION FOR ADJUVANT CONTAINING POLY-GAMMA-GLUTAMIC ACID
EP2123752A4 (en) NOVEL NUCLEIC ACID
EP2077326A4 (en) NOVEL NUCLEIC ACID
GB0514293D0 (en) Marking sample carriers
GB0502206D0 (en) Transport container
HK1171689A1 (en) Carrier composition for nucleic acid transport
TWI315287B (en) Container carrier
PL1888832T3 (pl) System zabezpieczenia transportowego
GB0502777D0 (en) Transport system
HK1139041A1 (en) Prompt nucleic acid delivery carrier composition
GB2434140B (en) Information carrier
HU3228U (en) Transport container
GB0602712D0 (en) Multimedia Traffic Handling Scheme
GB0515330D0 (en) Transport rack
AU303991S (en) Carrier
AU303990S (en) Carrier
AU304518S (en) Carrier
GB0521121D0 (en) Carrier
GB0516574D0 (en) Nucleic acid molecule
GB0512943D0 (en) Indazole-1-acetic acid compounds
ZAA200500799S (en) Bottle carrier
ZAA200500800S (en) Bottle carrier
GB0507118D0 (en) Bottle carrier
ZA200600564B (en) Bottle carrier
IL166594A0 (en) Flag carrier

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161017